CS
AMGN icon

Cannell & Spears’s Amgen AMGN Stock Holding History

Cannell & Spears’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.07M Sell
8,717
-2,386
-21% -$851K 0.06% 160
2025
Q4 		$3.63M Buy
11,103
+403
+4% +$128K 0.07% 154
2025
Q3 		$3.02M Sell
10,700
-2,652
-20% -$769K 0.06% 168
2025
Q2 		$3.73M Buy
13,352
+51
+0.4% +$14.4K 0.08% 159
2025
Q1 		$4.14M Sell
13,301
-357
-3% -$105K 0.09% 143
2024
Q4 		$3.56M Sell
13,658
-197
-1% -$58.4K 0.07% 150
2024
Q3 		$4.46M Buy
13,855
+169
+1% +$55.3K 0.09% 139
2024
Q2 		$4.28M Buy
13,686
+2,235
+20% +$657K 0.09% 129
2024
Q1 		$3.26M Buy
11,451
+7,936
+226% +$2.32M 0.07% 147
2023
Q4 		$1.01M Buy
3,515
+150
+4% +$40.9K 0.08% 98
2023
Q3 		$904K Hold
3,365
– – 0.08% 97
2023
Q2 		$747K Buy
3,365
+2,377
+241% +$552K 0.06% 113
2023
Q1 		$239K Sell
988
-196
-17% -$48.1K 0.02% 200
2022
Q4 		$311K Hold
1,184
– – 0.03% 176
2022
Q3 		$267K Sell
1,184
-109
-8% -$26.4K 0.03% 167
2022
Q2 		$315K Sell
1,293
-369
-22% -$90.4K 0.03% 166
2022
Q1 		$402K Sell
1,662
-2,700
-62% -$620K 0.03% 158
2021
Q4 		$981K Buy
4,362
+2,266
+108% +$478K 0.07% 105
2021
Q3 		$446K Hold
2,096
– – 0.03% 152
2021
Q2 		$511K Buy
+2,096
New +$516K 0.04% 145
2020
Q4 		– Sell
-1,929
Closed -$490K – 235
2020
Q3 		$490K Buy
+1,929
New +$478K 0.05% 130

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Cannell & Spears's AMGN Position: Q1 2026 in Review

Cannell & Spears reduced its Amgen (AMGN) stake by 21% in Q1 2026, selling an estimated $851K and leaving 8,717 shares worth $3.07M. The position accounts for 0.06% of the portfolio, ranked #160.

Cannell & Spears first reported a position in AMGN in Q3 2020 and has held it in 21 quarters since. The position peaked at $4.46M in Q3 2024. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Cannell & Spears held 8,717 shares of Amgen worth $3.07M as of Q1 2026.
  • Cannell & Spears sold 2,386 Amgen shares in Q1 2026, an estimated $851K.
  • Amgen made up 0.06% of Cannell & Spears's portfolio in Q1 2026, its #160 holding.
  • Cannell & Spears first reported a position in Amgen in Q3 2020 and has held it in 21 quarters since.
  • Cannell & Spears's Amgen position peaked at $4.46M in Q3 2024.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Cannell & Spears's 13F filing for Q1 2026, filed 14 May 2026.